Simplex Trading’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,800
| Closed | -$3.45M | – | 10250 |
|
|
2023
Q2 | $3.45M | Sell |
33,800
-42,800
| -56% | -$4.05M | ﹤0.01% | 1557 |
|
|
2023
Q1 | $6.96M | Buy |
76,600
+65,000
| +560% | +$3.81M | 0.01% | 1094 |
|
|
2022
Q4 | $440K | Sell |
11,600
-174,800
| -94% | -$6.02M | ﹤0.01% | 3305 |
|
|
2022
Q3 | $4.68M | Buy |
186,400
+156,400
| +521% | +$4.33M | 0.01% | 1249 |
|
|
2022
Q2 | $911K | Sell |
30,000
-120,500
| -80% | -$3.59M | ﹤0.01% | 2727 |
|
|
2022
Q1 | $4.93M | Buy |
150,500
+120,500
| +402% | +$3.58M | ﹤0.01% | 1251 |
|
|
2021
Q4 | $791K | Sell |
30,000
-8,600
| -22% | -$665K | ﹤0.01% | 3190 |
|
|
2021
Q3 | $5.52M | Hold |
38,600
| – | – | 0.01% | 1114 |
|
|
2021
Q2 | $5.46M | Buy |
38,600
+38,185
| +9,201% | +$4.31M | 0.01% | 1106 |
|
|
2021
Q1 | $4.14M | Buy |
415
+410
| +8,200% | +$47.8K | 0.01% | 968 |
|
|
2020
Q4 | $61K | Sell |
5
-55
| -92% | -$7.23K | ﹤0.01% | 5977 |
|
|
2020
Q3 | $584K | Buy |
60
+43
| +253% | +$5.37K | ﹤0.01% | 2810 |
|
|
2020
Q2 | $265K | Sell |
17
-29
| -63% | -$4.41K | ﹤0.01% | 3676 |
|
|
2020
Q1 | $663K | Sell |
46
-64
| -58% | -$12.4K | ﹤0.01% | 2301 |
|
|
2019
Q4 | $2.25M | Sell |
110
-4
| -4% | -$730 | ﹤0.01% | 1382 |
|
|
2019
Q3 | $915K | Buy |
114
+109
| +2,180% | +$9.25K | ﹤0.01% | 2018 |
|
|
2019
Q2 | $47K | Buy |
+5
| New | +$432 | ﹤0.01% | 4919 |
|
|
2019
Q1 | – | Sell |
-25
| Closed | -$140K | – | 8083 |
|
|
2018
Q4 | $140K | Sell |
25
-21
| -46% | -$1.28K | ﹤0.01% | 3515 |
|
|
2018
Q3 | $376K | Buy |
+46
| New | +$3.24K | ﹤0.01% | 2926 |
|
Simplex Trading's RETA Position: Q3 2023 in Review
Simplex Trading sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 17,884 shares — an estimated $2.69M sold.
Simplex Trading first reported a position in RETA in Q3 2017 and held it in 8 quarters. The position peaked at $1.82M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Simplex Trading reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Simplex Trading sold 17,884 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $2.69M.
- Simplex Trading first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2017 and held it in 8 quarters.
- Simplex Trading's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.82M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.